People with multiple sclerosis (MS) who have never received treatment with a disease-modifying therapy tend to have better…
Articles by Marisa Wexler, MS
A newly developed laboratory model using tadpoles can help determine the remyelinating potential of new multiple sclerosis (MS) therapies…
Blood levels of the nerve damage marker NfL seem to spike to very high levels around times of disease activity…
Rehabilitation therapy that utilizes virtual reality can help to improve balance and reduce the fear of falling for people with…
Nearly half of the people with relapsing forms of multiple sclerosis (MS) treated early with Ocrevus (ocrelizumab) in…
More than 80% of patients with relapsing forms of multiple sclerosis (MS) given Kesimpta (ofatumumab) continuously for up…
There was no evidence of multiple sclerosis (MS) disease activity for at least two years in patients who underwent…
More than 90% of Black and Hispanic patients with multiple sclerosis (MS) treated with Ocrevus (ocrelizumab) in a…
Treatment with Aubagio (teriflunomide) significantly reduces the risk that adults with radiologically isolated syndrome (RIS) will develop symptoms of…
Supplements with tauroursodeoxycholic acid (TUDCA) were generally well tolerated among people with progressive forms of multiple sclerosis (MS), according…
Use of the cell therapy MSC-NP failed to show a significant effect on overall disability scores among people with progressive…
Damage to the myelin sheath, a hallmark feature of multiple sclerosis (MS), leads to increased levels of fatty molecules…
Most treatments for multiple sclerosis (MS) are not associated with an increased risk of complications during pregnancy, according to…
People with secondary progressive multiple sclerosis (SPMS) seem to experience slower worsening of their disabilities than those with the…
A novel formulation of ibudilast, delivered into the nose, was able to reduce inflammation and prevent nerve damage in…
Scientists have developed new skin patches that could offer a more convenient and less painful way to administer antibody-based medicines…
Abnormal perceptions of discomfort and fatigue likely play a role in causing increased heat and cold sensitivity to extreme temperatures…
People with multiple sclerosis (MS) tend to accrue more medical costs after switching to infusible therapies Ocrevus (ocrelizumab),…
The way Ocrevus (ocrelizumab) affects immune cell profiles of people with multiple sclerosis (MS) varies depending on what…
Issues with sexual performance and satisfaction are common with multiple sclerosis (MS), and show significant associations with measures of…
Clinical trials testing rehabilitation strategies for people with multiple sclerosis (MS) include a disproportionate number of white participants and…
People with primary progressive multiple sclerosis (MS) may experience more severe inflammatory activity and nerve damage early on in…
A team of scientists has developed a wearable microscope — to be carried on the backs of animals in a…
A pair of experts are calling for genetic tests to be developed to identify people at higher risk of developing…
A new podcast series called “A Campbell Never Quits” is telling the life story of Tyler Campbell, a patient advocate…
Because people with multiple sclerosis (MS) usually undergo regular MRI scans to image their brains, their data could…
Transcutaneous electrical nerve stimulation (TENS) and interferential currents (IFC) — both interventions apply electrical stimulation through electrodes placed on the…
MSC-NP, a form of stem cell therapy that’s currently in early clinical trials for multiple sclerosis (MS), can reduce…
Neurologists in the U.S. are generally favoring more aggressive early treatment for multiple sclerosis (MS), according to an…
Can Do MS has three missions for people with multiple sclerosis (MS) and their care partners — providing…